Glancy Prongay & Murray LLP, a Leading Securities Fraud Law

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
40
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of InnerWorkings, Inc. (INWK) on Behalf of Investors

LOS ANGELES, April 04, 2020 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of InnerWorkings, Inc. (“InnerWorkings” or “the Company”) (NASDAQ: INWK ) investors concerning the Company and its officers’ possible violations of the federal securities laws.

If you suffered a loss on your InnerWorkings investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information  here  or contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, via email shareholders@glancylaw.com or visit our website at www.glancylaw.com to learn more about your rights.

On March 16, 2020, InnerWorkings issued a press release revealing the Company’s financial and operating results for the fourth quarter and full year 2019. Therein, the Company’s Chief Financial Officer stated that, “[a]s a result of the material weaknesses previously disclosed, insufficient evidence existed to support the recognition of revenue in arrangements containing bill and hold provisions. Therefore, we deferred the related revenue until product shipped from our warehouse.”

On this news, the Company’s share price fell $0.36, or over 17%, to close at $1.68 per share on March 17, 2020, thereby injuring investors.

Follow us for updates on LinkedIn , Twitter , or Facebook .

Whistleblower Notice: Persons with non-public information regarding InnerWorkings should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program. Under the program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Charles H. Linehan at 310-201-9150 or 888-773-9224 or email shareholders@glancylaw.com .

About GPM Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation. ISS Securities Class Action Services has consistently ranked GPM in its annual SCAS Top 50 Report. In 2018, GPM was ranked a top five law firm in number of securities class action settlements, and a top six law firm for total dollar size of settlements. With four offices across the country, GPM’s nearly 40 attorneys have won groundbreaking rulings and recovered billions of dollars for investors and consumers in securities, antitrust, consumer, and employment class actions. GPM’s lawyers have handled cases covering a wide spectrum of corporate misconduct including cases involving financial restatements, internal control weaknesses, earnings management, fraudulent earnings guidance and forward looking statements, auditor misconduct, insider trading, violations of FDA regulations, actions resulting in FDA and DOJ investigations, and many other forms of corporate misconduct. GPM’s attorneys have worked on securities cases relating to nearly all industries and sectors in the financial markets, including, energy, consumer discretionary, consumer staples, real estate and REITs, financial, insurance, information technology, health care, biotech, cryptocurrency, medical devices, and many more. GPM’s past successes have been widely covered by leading news and industry publications such as The Wall Street Journal , The Financial Times , Bloomberg Businessweek , Reuters , the Associated Press , Barron’s , Investor’s Business Daily , Forbes , and Money .

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts Glancy Prongay & Murray LLP, Los Angeles Charles H. Linehan, 310-201-9150 or 888-773-9224 1925 Century Park East, Suite 2100 Los Angeles, CA 90067 www.glancylaw.com shareholders@glancylaw.com

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cepheid's FDA Clearance Boosts Hemorrhagic Fever Test

Updated Category News Views 81

Quick Detection for Deadly Viruses In the world of diagnostics, speed isn't just a luxury; it's a lifeline. Cepheid’s latest move—getting the FDA’s nod for their Xpert Hemorrhagic Fever Panel Test—is a big deal. Why? Imagine being able to detect nasty viruses like Ebola, Marburg, Lassa, and Crimean-Congo hemorrhagic fever in just over an hour. That's what this...

Continue Reading
Icahn Faces $225M Q3 Loss, But CVR Deal Shines

Updated Category News Views 30

Icahn Enterprises Stumbles in Q3, Losses Widen When a company's financial report starts with a loss, it's like stepping into a bar fight expecting cheers—you’re bound to get more than you bargained for. Icahn Enterprises L.P.'s third quarter report isn't exactly a rosy picture. We're staring down the barrel of a net loss of $225 million, a sharp contrast to the $287...

Continue Reading
MINISO Prepares to Reveal September 2026 Results

Updated Category News Views 74

News flash, folks — MINISO Group, that quirky IP-driven retailer we all have an eye on, has set the stage for its next big reveal. Come November 17, 2026, they’re gonna lay down their financial cards for the September quarter. It’s prime time for any investor keen on dissecting their performance and plans for the future. What the Call Means for Stakeholders MINISO's...

Continue Reading
Differentia Bio's AI: Transforming Drug Development Dynamics

Updated Category News Views 51

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

Continue Reading
ISU and Ares Forge Path in Solid-State Battery Tech

Updated Category News Views 57

Solid-State Dreams Meet AI Magic Ah, the sweet sound of synergy. ISU Specialty Chemical and Ares Materials are brewing up something that could shake the battery world—solid-state cells juiced by AI-driven polymer magic. Now, the tech and finance geeks are likely on the edge of their seats. This isn't just another run-of-the-mill collab; it's a heavyweight match to speed...

Continue Reading
Doximity Faces Class Action: Investor Guidance Needed

Updated Category News Views 37

Doximity Lands in Hot Water: The Stakes for Investors Alright, traders, there's a storm brewing around Doximity (NYSE:DOCS), and it's a doozy. A class action lawsuit has been slapped on this digital platform for medical pros, and the accusations are serious. If you rode the wave and snagged yourself some shares between August 8, 2024, and May 13, 2026, you're right in the...

Continue Reading
RepData's New Platform Redefines Market Research Game

Updated Category News Views 34

Ever look at your market research and think, 'Is this really the best we can do?' RepData just rolled up like they own the place with their Verified Intelligence Platform (VIP), promising to make those wild data quality doubts a thing of the past. RepData’s Game-Changer in Research RepData's stepping into the ring with their VIP, aiming to shake up the way research...

Continue Reading
Oracle's $20 Billion Offering: What Investors Need to Know

Updated Category News Views 118

Oracle's Big Play: A $20 Billion Offering Nobody said playing in the big leagues was easy, and Oracle seems to be doubling down on that idea. Today, they spilled the beans on their ambition to rake in a cool $20 billion through an offering of common stock and senior notes. For those of us who keep a close eye on NYSE:ORCL, this is more than just a number—it's a signal...

Continue Reading
PRIMA Invests £10M to Propel CC Forum's Global Reach

Updated Category News Views 98

Strategic Commitment for Global Impact You've got to hand it to these folks—they're on a mission to roll up their sleeves and tackle climate change head-on. Max Studennikoff, the brains behind CC Forum, just inked a Letter of Intent with Alexander Zhardanovsky, founder of PRIMA, punctuated by an eye-popping £10 million pledge. It's all about boosting the Forum’s...

Continue Reading
Handle Plumbing Emergencies Swiftly, Expert Advises

Updated Category News Views 49

Fast Response Crucial in Plumbing Crises It's like nature's way of testing your mettle: a sudden plumbing emergency can make any homeowner feel like they're in over their head. The trick lies in how fast you act, and let me tell you, speed is everything in these situations. If you’ve never stared down a burst pipe or felt your heart drop at an overflowing toilet,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth and Trends in Nuclear Medicine

Updated Category News Views 326

Nuclear Medicine Market Trends and Growth Projections Nuclear medicine is becoming an essential part of modern healthcare systems, offering significant diagnostic and therapeutic benefits. Recent industry analysis shows that the nuclear medicine market, valued at US$ 5.2 billion in 2022, is projected to grow to an astounding US$ 11.4 billion by 2031. This growth...

Continue Reading
Bitcoin Resilience: Experts Forecast Continued Growth Amid Dip

Updated Category News Views 107

Experts Forecast Bitcoin's Continued Growth In recent discussions, cryptocurrency experts have expressed a common belief that Bitcoin's long-term trajectory remains robust despite current fluctuations. Bitcoin has faced challenges in the short term, but the overarching consensus suggests that its bull market is far from over. The Impact of Federal Reserve Policies...

Continue Reading
Iovance Investors Urged to Act Before the July 14 Deadline

Updated Category News Views 170

Important Notice for Iovance Investors Levi & Korsinsky, LLP is reaching out to investors of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) regarding a class action securities lawsuit. This notice serves to inform shareholders of the impending deadline for becoming a lead plaintiff, which is set for July 14, 2025. Class Action Overview The legal action aims to recover...

Continue Reading
Startek® South Africa Achieves Best Employer Brand Award

Updated Category News Views 256

Startek® South Africa Celebrates Employer Branding Success Startek®, a leader in global customer experience solutions, is making waves in the industry with its recent accolade at the South Africa Leadership Awards. Startek's South Africa operations received the prestigious Best Employer Brand Award for 2025, recognizing their exceptional approach to employee engagement...

Continue Reading
ESS Tech Launches Energy Center™ Product for Sustainable Energy

Updated Category News Views 220

ESS Tech Introduces Energy Center™ Product ESS Tech, Inc. (NYSE: GWH), a frontrunner in the field of long-duration energy storage systems, has proudly announced the commercial launch of its innovative Energy Center™ product. This milestone comes with the successful delivery of multiple systems to a prominent utility in Florida, along with the completion of...

Continue Reading